70
Participants
Start Date
February 5, 2025
Primary Completion Date
May 1, 2028
Study Completion Date
August 1, 2028
ARC101
ARC101 will be administered according to an assigned dose schedule.
RECRUITING
Cabrini Health Research, Malvern
RECRUITING
Sunshine Coast University Private Hospital, Birtinya
RECRUITING
Cancer Research SA, Adelaide
RECRUITING
START Midwest, Grand Rapids
NOT_YET_RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
START San Antonio, LLC., San Antonio
RECRUITING
Rambam Medical Center, Haifa
RECRUITING
Sourasky Medical Center, Tel Aviv
RECRUITING
BC Cancer Research Centre, Vancouver
RECRUITING
The Princess Margaret Cancer Centre, Toronto
Lead Sponsor
Third Arc Bio
INDUSTRY